Targeting PTSD with ultramicronized palmitoylethanolamide: Results from a randomized trial integrating pharmacotherapy and cognitive behavioral therapy
PEA-um, especially when combined with CBT, represents a promising and well-tolerated adjunctive treatment for PTSD, warranting further validation in larger clinical trials.
Authors
- Francesco Monaco (ORCID: https://orcid.org/0000-0002-1854-292X)
- Michele Fornaro (ORCID: https://orcid.org/0000-0002-9647-0853)
- Luca Steardo (ORCID: https://orcid.org/0000-0002-7077-3506)
- Valeria Di Stefano (ORCID: https://orcid.org/0009-0006-2333-0637)
Institutions
- Magna Graecia University (IT)
- Federico II University Hospital (IT)
- European Biomedical Research Institute of Salerno (IT)
- Giustino Fortunato University (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Journal of Psychiatric Research
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1016/j.jpsychires.2025.10.071
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00